leadf
logo-loader
viewBioLargo, Inc.

BioLargo says interest is 'extreme' in its Clyraguard spray that dispels the coronavirus

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that Clyraguard, a spray developed by its subsidiary Clyra Medical Technologies, was shown to cause complete inactivation of the coronavirus in lab testing.

Calvert says Clyraguard is a personal protective spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment from the coronavirus.

Quick facts: BioLargo, Inc.

Price: 0.14295 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $31.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo's water technologies closer to commercialization, reports record 3Q

BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which...

1 week, 2 days ago

2 min read